Has Lora Christian received payments from drug or device companies?

Yes. Drug and device makers reported $2,169 in general payments to Lora Christian across 110 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lora Christian did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lora Christian come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lora Christian

Adolescent Medicine · Richmond, VANPI 1558390161

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $662 and has fallen 54.0% since, to $305 in 2025.

$2,169in general payments, 2019–2025

Across 110 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ironshore Pharmaceuticals Inc.$371
Tris Pharma Inc$354
Corium, LLC$307
Kaleo, Inc.$210
Collegium Pharmaceutical, Inc.$143
Pfizer$142
plus $642 from 15 others

What the payments were for

Food & beverage$2,169100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ironshore Pharmaceuticals Inc.	19	$371
Tris Pharma Inc	15	$354
Corium, LLC	12	$307
Kaleo, Inc.	12	$210
Collegium Pharmaceutical, Inc.	8	$143
Pfizer	8	$142
Takeda Pharmaceuticals U.S.A., Inc.	6	$114
Merck	5	$80
Neos Therapeutics, LP	5	$76
Sanofi Pasteur Inc.	3	$68
Genentech USA, Inc.	3	$52
GSK	2	$39
Supernus Pharmaceuticals, Inc.	2	$32
ARS Pharmaceuticals Operations, Inc.	1	$29
Alk-abello, Inc	1	$29
Adlon Therapeutics L.p.	2	$27
Cranial Technologies, Inc	2	$26
Biogen	1	$24
LNHC, Inc	1	$19
Shire North American Group Inc	1	$16
Phadia US Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,169 in reported general payments places this provider in the 75th percentile of 49 adolescent medicine providers in Virginia.

See all adolescent medicine providers in Virginia →

Other adolescent medicine in Richmond

Peter HeymanRichmond$3K
Melani de SilvaRichmond$3K
Charles TerryRichmond$2K
Cheryl BelleRichmond$1K
Jocelyn VergaraRichmond$1K
Cristi WilsonRichmond$216
Stephanie CreweRichmond$124
George RoweRichmond$102
Adam FalikRichmond$82
An PhamRichmond$76

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →